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Abstract
CD8+ T cell exhaustion represents a major hallmark of chronic HIV infection. Two key transcription factors governing CD8+ T
cell differentiation, T-bet and Eomesodermin (Eomes), have previously been shown in mice to differentially regulate T cell
exhaustion in part through direct modulation of PD-1. Here, we examined the relationship between these transcription
factors and the expression of several inhibitory receptors (PD-1, CD160, and 2B4), functional characteristics and memory
differentiation of CD8+ T cells in chronic and treated HIV infection. The expression of PD-1, CD160, and 2B4 on total CD8+ T
cells was elevated in chronically infected individuals and highly associated with a T-betdimEomeshi expressional profile.
Interestingly, both resting and activated HIV-specific CD8+ T cells in chronic infection were almost exclusively T-
betdimEomeshi cells, while CMV-specific CD8+ T cells displayed a balanced expression pattern of T-bet and Eomes. The T-
betdimEomeshi virus-specific CD8+ T cells did not show features of terminal differentiation, but rather a transitional memory
phenotype with poor polyfunctional (effector) characteristics. The transitional and exhausted phenotype of HIV-specific
CD8+ T cells was longitudinally related to persistent Eomes expression after antiretroviral therapy (ART) initiation. Strikingly,
these characteristics remained stable up to 10 years after ART initiation. This study supports the concept that poor human
viral-specific CD8+ T cell functionality is due to an inverse expression balance between T-bet and Eomes, which is not
reversed despite long-term viral control through ART. These results aid to explain the inability of HIV-specific CD8+ T cells to
control the viral replication post-ART cessation.
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Introduction
An effective CD8+ T cell response is required to eradicate or
control intracellular pathogens. During the acute phase of an
infection, pathogen-specific CD8+ T cells expand and differen-
tiate into effector cells to clear the microbe. In the wake of
antigen clearance, long-lived memory CD8+ T cells develop in
order to launch an effective secondary response against future
infections. Murine studies have indicated that the process of
memory formation is highly regulated by the T-box transcrip-
tion factors T-bet and Eomesodermin (Eomes) [1,2,3]. Although
T-bet and Eomes are related transcription factors that show
some expressional overlap, their functional roles are not entirely
reciprocal. Whereas T-bet regulates the expression of effector
functions, Eomes is thought to primarily dictate the expression
of proteins to maintain a memory CD8+ T cell repertoire that
effectively could expand in case of re-infection [4,5,6,7]. The
current body of data thus suggest that the long-term fate of
CD8+ T cell functionality and differentiation seems highly
dictated by the expression ratio between T-bet or Eomes
(reviewed in [8]).
Some viruses, including the human immunodeficiency virus
type 1 (HIV), evade the immune defense and develop into chronic
infection. As a consequence, the pool of HIV-specific CD8+ T
cells persists throughout the infection and become dysfunctional.
This process has usually been referred to as CD8+ T cell
exhaustion, which is characterized by a typical loss of different
functions, including the ability to proliferate, kill target cells
(expression of cytotoxic molecules), and decreased IL-2, TNF, and
IFNc production [9,10]. Initially, murine studies revealed that
chronic lymphocytic choriomeningitis virus clone 13 (LCMV-13)
infection caused an up-regulation of PD-1 [11] and other
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inhibitory receptors, like CD160, 2B4, and Lag-3, which
cooperate to mediate CD8+ T cell dysfunction [12]. These
findings were later extended to chronic human infections including
HIV [13,14,15,16], HCV [17,18,19,20], and HBV [21,22,23]. In
particular, HIV-specific CD8+ T cells have been studied with
respect to dysfunctional characteristics, where seminal work have
concluded that these cells in most individuals possess poor
polyfunctionality [24,25], and an immature/skewed maturation
phenotype [26,27]. However, it remains unclear which transcrip-
tional programming that governs the regulation of CD8+ T cell
differentiation and exhaustion in HIV infection.
Transcriptional networks have been related to CD8+ T cell
exhaustion after LCMV-13 infection in mice [28], and recently
also in HIV-specific CD8+ T cells specifically expressing PD-1
[29] and CD160 [30]. Lately, Wherry and colleagues have
elucidated in the murine model that an exhausted profile following
LCMV-13 infection is associated with an inverse relationship
between T-bet and Eomes [31,32]. Surprisingly, these studies
showed that although T-bet caused terminal differentiation of
CD8+ T cells, the transcription factor repressed expression of
inhibitory receptors by direct binding to the promoter region of
PD-1. Eomes on the other hand was highly associated with
expression of numerous inhibitory receptors. In a recent study,
long-term non-progressors were shown to retain high T-bet
expression within HIV-specific CD8+ T cells [33]. However, it is
currently unknown whether the expression levels of T-bet and
Eomes in human virus-specific CD8+ T cells are associated with
the up-regulation of inhibitory receptors, poor polyfunctionality,
and the skewed maturation phenotype described in HIV-infected
individuals.
To bring clarity to this, we examined the relationship between
the expression of T-box transcription factors, markers of memory
differentiation, and human viral-specific CD8+ T cell exhaustion
at the single cell level. We provide evidence that HIV-specific
CD8+ T cells in chronic infection largely possess highly elevated
levels of Eomes, but lower T-bet expression. This relationship is
associated with up-regulation of inhibitory receptors, impaired
functional characteristics and a transitional memory differentiation
phenotype. Importantly, these characteristics of HIV-specific
CD8+ T cells remained stable despite suppressive ART for many
years, and offer an explanation for the inability of CD8+ T cells to
control viral replication post-ART cessation.
Methods
Ethics statement
The Regional Ethical Council (Stockholm, Sweden 2012/999-
32 & 2009/1592-32) approved the study and all participants were
provided with written and oral information about the study.
Written informed consent was documented from all study subjects
in accordance with the Declaration of Helsinki.
Study participants
All HIV-infected individuals were recruited from the Karolinska
University Hospital Huddinge and Venha¨lsan at Stockholm South
General Hospital (Stockholm, Sweden). In total, 52 individuals
with chronic untreated HIV infection and 12 HIV-infected
individuals on ART for more than 10 years (fully suppressed viral
load for .8 years) were enrolled in this study. Cell samples from
20 healthy controls were also collected from the Karolinska
Institutet and Karolinska University Hospital Huddinge (Table 1).
Out of the 52 individuals with chronic untreated HIV infection, 24
individuals were followed longitudinally from baseline (median = 0
days before ART initiation) and at 2 weeks, 4 weeks, 8 weeks, 12–
16 weeks and 5–7 months post-ART initiation. All individuals
initiated ART in chronic phase of infection and no one
experienced virological failure (i.e. .200 HIV RNA copies/mL
after 6 months on therapy) (Table S1).
Cells and peptides
Peripheral blood mononuclear cells (PBMCs) were isolated from
whole blood by Hypaque-Ficoll (GE Healthcare) density gradient
centrifugation and cryopreserved in FBS (Life Technologies)
containing 10% DMSO. For detection of HIV- and CMV-specific
T cell responses, peptide pools (15-mers overlapping by 11 amino
acids) of HIV Gag-p55 (JPT technologies) and HCMV pp65 (NIH
AIDS Research and Reference Reagent Program) were added to a
final concentration of 1 mg/mL.
Antibody reagents
All flow cytometry panels were tested on the HIV-infected and
healthy control subjects within a 2-month time interval to avoid
intra- and inter-individual differences of the flow analysis. The
following antibodies were used: anti-CD3 APC-H7 (Clone SK7),
anti-CD14 V500 (Clone M5E2), anti-CD19 V500 (Clone B43),
anti-CD160 AF488 (Clone BY55), anti-CCR7 PE-Cy7 (Clone
3D12), anti-IFNc AF700 (Clone B27), anti-TNF PE-Cy7 (Clone
MAb11), anti-CD107a PE-CF594 (Clone H4A3), anti-HLA-DR
BV605 (Clone G46) (BD Bioscience); anti-2B4 PE-Cy5.5 (Clone
C1.7), anti-CD45RO ECD (clone UCHL1) (Beckman Coulter);
anti-T-bet BV605 & -BV711 (clone B10), anti-CD4 BV650 & -
BV785 (Clone OKT4), anti-PD-1 BV421 (clone EH12.2H7), anti-
CD27 BV785 (clone O323), anti-CD38 APC (clone HIT2), anti-
IL-2 BV605 (Clone MQ1-17H12), anti-Perforin BV421 (clone B-
D48), anti-Granzyme A AF488 (clone CB9) (Biolegend); anti-T-
bet PE (clone B10), anti-Eomes EF660 (clone WD1928)
(eBioscience); anti-CD8 Qd565 (Clone 3B5), anti-CD4 PE-Cy5.5
(Clone S3.5), anti-Granzyme B PE-Cy5.5 (Clone GB11) (Life
Technologies). LIVE/DEAD Aqua amine dye (Life Technologies)
was used to discriminate dead cells and debris. MHC class-I
tetramers and pentamers conjugated to PE (Beckman Coulter and
ProImmune) were used to detect CD8+ T cells specific for HIV
Gag SLYNTVATL (SL9)/HLA-A*0201, HIV Pol ILKEPVHGV
Author Summary
CD8+ T cells display numerous traits of severe dysfunction
in both treated and untreated HIV infection. Previous
studies have demonstrated that HIV-specific CD8+ T cells
in most individuals possess poor polyfunctionality, and an
immature/skewed maturation phenotype. However, it
remains unclear which transcriptional programming gov-
erns the regulation of CD8+ T cell differentiation and
exhaustion in HIV infection. T-bet and Eomes represent
two key transcription factors for CD8+ T cell differentiation
and function, but surprisingly little is known about their
influence of effector immunity following chronic viral
infections in humans. In this study, we demonstrate that
HIV-specific CD8+ T cells possess highly elevated levels of
Eomes, but low T-bet expression. This differential relation-
ship is linked to the up-regulation of several inhibitory
receptors, impaired functional characteristics and a tran-
sitional memory differentiation phenotype for virus-
specific CD8+ T cells. Importantly, these characteristics of
HIV-specific CD8+ T cells remained stable despite suppres-
sive ART for many years. These results implicate that
reinvigoration of these cells might fail to elicit efficient
responses to eradicate the viral reservoir.
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(IV9)/HLA-A*0201 and CMV pp65 NVLPMVATV (NV9)/
HLA-A*0201.
Stimulation and intracellular staining of cells
PBMCs were thawed and washed twice in R10 (RPMI-1640
Medium AQmedia (Sigma Aldrich) containing 10% FBS, 50 IU/
mL penicillin and 50 mg/mL streptomycin, 10 mM HEPES (Life
Technologies)). Cells were counted on a Nucleocounter (Chemo-
Metec A/S), resuspended to 26106 cells/mL in R10 containing
10 U/mL DNase I (Roche Diagnostics) and rested for 5–6 hours
at 37uC.
U-bottom plates were plated with 5 mg/mL Brefeldin A (Sigma
Aldrich) and overlapping HIV Gag-p55 and HCMV pp65
peptides or medium alone (negative controls) together with
26106 PBMCs/well. When anti-CD107a was added at the start
of the stimulation protocol [34], monensin (0.7 mg/mL, BD
Bioscience) was also supplemented.
The PBMCs were next transferred to V-bottom plates,
washed in PBS containing 2 mM EDTA and stained with a
LIVE/DEAD Aqua amine dye solution containing the
extracellular antibodies. Cells were first incubated for 10 min-
utes at 37uC with an anti-CCR7 antibody and then for further
20 minutes in room temperature with other extracellular
antibodies. PBMCs were washed in PBS:EDTA and fixed
and permeabilized using the FoxP3 transcription factor buffer
kit (eBioscience). Monoclonal antibodies against T-bet, Eomes
and other intracellular markers were incubated with the cells
for 1 hour at room temperature in the dark. After further
washing with Perm Wash solution (eBioscience), the PBMCs
were resuspended in PBS containing 1% paraformaldehyde
PFA. All specimens were acquired on the flow cytometer
within the next 7 hours.
Flow cytometric analyses
PBMCs were analyzed on a modified 4 laser LSR Fortessa
(BD Biosciences). In total, approximately 1,000,000 events
were collected per specimen. Antibody capture beads (BD
Biosciences) were used to prepare individual compensation
controls after separate stainings with all antibodies used in the
experiments. FlowJo 8.8.7 (Treestar) was used for flow
cytometric gating analyses. Most manual gatings were based
on fluorescence minus one (FMO) gating strategies like
previously described [35,36]. A response was considered
positive if the frequency of IFNc producing cells were .
0.05% of total CD8+ T cells after background reduction and
twice the negative background.
ELISA
Plasma was extracted from whole blood and stored in 280uC
before analysis of soluble factors. Concentrations of cytokines in
plasma were analyzed by ELISA using the following reagents:
Ready-Set-Go, eBioscience (TNF, IL-6), Matched Antibody Pairs,
eBioscience (IFNa) and HS Quantikine, RnD Systems (IL-12p70)
according to the manufacturer’s specifications.
Statistics
Experimental variables between two groups of individuals were
analyzed using Mann-Whitney U test and Wilcoxon matched-
pairs rank test. Correlations were assessed using non-parametric
Spearman rank tests. Bonferroni corrections were applied to all
cases where multiple testing was performed. One-Way ANOVAs
followed by Kruskal-Wallis non-parametric Dunn’s multiple
comparison tests were used to analyze three groups or more.
The large data set consisting of functional and inhibitory receptor
frequencies from the Boolean combinations was analysed by
principal component analysis (PCA), an unsupervised statistical
method for reducing data dimensionality while retaining the vital
variation in fewer informative variables. The top 2 principle
components (PCs) were plotted to visualize the trends such as
clusters and outliers revealed by PCA. The Kolmogorov-Smirnov
test was used to test the null hypothesis that the two groups of
samples were drawn from the same distribution, where a large p-
value suggests that the groups were drawn from the same
distribution. All the statistical analyses were performed using
GraphPad Prism 5.0 and R environment [37]. Permutation tests
were analyzed using the data analysis program SPICE version
5.2009 [38].
Results
T-betdimEomeshi CD8+ T cells express high levels of
inhibitory receptors
Previous studies have identified numerous inhibitory receptors,
including PD-1, CD160, 2B4, LAG-3, CTLA4, and Tim-3, with
increased expression patterns after chronic viral infections
[13,14,15,16,39,40]. Due to low and partly negligible expression
of LAG-3, CTLA4 and Tim-3 on virus-specific CD8+ T cells (data
not shown and [16]), we here focused on studying the expression
of PD-1, CD160 and 2B4 on memory CD8+ T cells in HIV-
infected individuals compared to healthy controls, and in relation
to T-bet and Eomes expression. As expected, we found increased
levels of CD8+ T cells mono- and co-expressing PD-1, CD160,
and 2B4 in our cohort of 52 untreated HIV-infected individuals,
Table 1. Cohort characteristics.
HIV+ (ART2)A HIV+ (ART+)B Healthy controls
n 52 12 20
Age, years 38 (33–46) 48 (45–57) 37 (31–42)
Sex, n (%) 60% Males 40% Females 75% Males 25% Females 75% Males 25% Females
CD4 count, cells/ml 395 (245–550) 690 (590–940) NDC
HIV RNA, copies/ml 28550 (3528–118500) ,50 NAD
Median (IQR) is shown for all parameters except n and sex.
A = Untreated HIV infected subjects.
B = Long-term treated HIV infected subjects.
CND = Not Determined.
DNA = Not Applicable.
doi:10.1371/journal.ppat.1004251.t001
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compared to long-term treated (.10 years) HIV-infected subjects
and healthy controls (Figure 1A and Figure S1A). However, no
significant differences in frequency of CD8+ T cells expressing the
inhibitory receptors was observed between the long-term treated
HIV+ subjects and healthy controls (Figure 1A).
We next examined whether the expression pattern of T-bet and
Eomes was linked to mono- and co-expression of PD-1, CD160,
and 2B4 within the total CD8+ T cell population. A close
relationship of increased expression of all inhibitory markers was
observed for T-betdim and Eomeshi CD8+ T cells (Figure S1B),
thus corroborating murine studies of LCMV-specific CD8+ T cells
[31]. We used a gating strategy similar to that recently described
on CMV-specific CD8+ T cells [41], and gated on T-
bethiEomesdim and T-betdimEomeshi CD8+ T cells (Figure 1B).
In all untreated HIV-infected subjects, the T-bethiEomesdim
population contained significantly fewer cells with mono- and
co-expression patterns of PD-1, CD160, and 2B4, as compared to
T-betdimEomeshi cells (Figure 1B–C). By gating on PD-1+CD160+
2B4+ CD8+ T cells, we found that the vast majority (medi-
an = 91.7%) of these cells were T-betdimEomeshi (Figure 1D).
Further corroborating this link, we discovered that CD8+ T cells
expressing inhibitory receptors was significantly associated with a
T-betdimEomeshi phenotype (Figure 1E). Notably, similar associ-
ations were also observed for individuals on long-term ART and
matched healthy controls (Figure S1C). Together, these results
indicate that an inverse expression pattern of T-bet and Eomes is
highly associated with the up-regulation of several inhibitory
receptors for total CD8+ T cells, independently of HIV infection
status.
Elevated expression of Eomes is a hallmark of HIV-specific
CD8+ T cells
As bulk CD8+ T cell expression of PD-1, CD160, and 2B4 was
highly correlated with the T-betdimEomeshi population, we next
examined whether this relationship could be attributed to HIV-
and other human viral-specific CD8+ T cells in general. We
therefore stimulated PBMCs with overlapping peptide pools
spanning HIV Gag-p55 and HCMV-pp65 to identify IFNc/
TNF-producing HIV- and CMV-specific CD8+ T cells, respec-
tively [36,42]. CMV-specific CD8+ T cell responses were selected
as a control, since these responses have previously been shown to
be highly polyfunctional and express less inhibitory receptors
[16,43,44]. In Figure 2A, an example is shown for typical HIV-
and CMV-specific IFNc+/TNF+ responses. Notably, HIV-specif-
ic CD8+ T cells (n = 50) were almost exclusively T-betdimEomeshi,
while CMV-specific CD8+ T cells (n = 46) could be detected in
both the T-betdimEomeshi and T-bethiEomesdim populations in all
untreated HIV-infected individuals with chronic disease
(Figure 2A–B). The median fluorescence intensity (MFI) of Eomes
and T-bet, was also significantly different between HIV- and
CMV-specific CD8+ T cells (Figure S2A). Consistently, both the
frequency and MFI of single and co-expression of PD-1, CD160,
and 2B4 were elevated on HIV-specific compared to CMV-
specific CD8+ T cells (Figure 2C and Figure S2B). We further
gated on PD-1+CD160+2B4+ HIV-specific CD8+ T cells and
found that this population almost exclusively were occupied within
the T-betdimEomeshi population (Figure 2D). By employing a
SPICE analysis on HIV-specific CD8+ T cells, we further
confirmed that co-expression of the inhibitory receptors were
significantly elevated in the T-betdimEomeshi population compared
to T-bethiEomesdim cells (P,0.001; Figure 2E).
In further analysis we compared the relationship between
expression of T-bet, Eomes, and inhibitory receptors among
unmanipulated (resting) virus-specific CD8+ T cells. To this end,
we directly examined HIV Gag SLYNTVATL (SL9) and CMV
pp65 NVLPMVATV (NV9) specific CD8+ T cells in 5 HLA-
A*0201+ donors, identified previously [45], by HLA class-I
tetramer (tet) analysis. In agreement with our previous results,
the HIV/SL9-tet+ cells had significantly higher levels of Eomes,
but lower T-bet expression than CMV/NV9-tet+ cells (Figure 3A–
B). The frequencies of CD8+ T cells mono- and co-expressing PD-
1, CD160, and 2B4 were highly elevated among HIV/SL9-tet+
cells, compared to CMV/NV9-tet+ T cells (Figure 3C). Combin-
ing both HIV/SL9-tet+ and CMV/NV9-tet+ cells in one
correlation analysis, we found an inverse correlation (P = 0.009,
r =20.79) between the MFI of T-bet and PD-1+CD160+2B4+ co-
expression (Figure 3D). Similarly, a positive strong association
(P = 0.006, r = 0.82) was observed between the MFI of Eomes and
PD-1+CD160+2B4+ co-expression (Figure 3D). Together, these
results show that human virus-specific CD8+ T cell regulation of
inhibitory receptors is associated with high expresison of Eomes,
but low T-bet expression.
Limited virus-specific CD8+ T cell functionality is related
to co-expression of inhibitory receptors and T-
betdimEomeshi cells
Co-expression of PD-1, CD160, and 2B4 has been closely
linked to limited T cell functionality in mice and humans [12,16].
Therefore, we next examined how differential expression of T-bet
and Eomes was related to the functional properties of HIV- and
CMV-specific CD8+ T cells in the context of these inhibitory
markers. We assessed the expression pattern for IFNc, TNF, IL-2,
CD107a and Granzyme B simultaneously for both HIV- and
CMV-specific CD8+ T cell responses in 23 untreated individuals
with chronic HIV infection. All individuals generated responses,
except one with lack of an anti-CMV response. PD-1+ HIV-
specific IFNc+ CD8+ T cells were found to be T-betdimEomeshi,
whereas PD-12 HIV-specific IFNc+ CD8+ T cells were T-
bethiEomesdim (Figure 4A). The PD-1+ T cell response showed low
co-expression of IFNc with either TNF or Granzyme B.
Interestingly however, we found that expression of CD107a
together with IFNc was more substantial in PD-1+ cells compared
Figure 1. Expression patterns of inhibitory receptors and T-bet/Eomes on total CD8+ T cells. (A) The percentage expression of PD-1,
CD160, 2B4 and co-expression of PD-1+CD160+2B4+ on total CD8+ T cells in chronic untreated HIV infected subjects, HIV+ (ART2) (n = 52);
individuals on long-term ART, HIV+ (ART+) (n = 12); and healthy controls, HCs (n = 20). Statistical analysis was performed with one-way ANOVA, non-
parametric Kruskal Wallis test with Dunn’s multiple comparison test to compare all pairs of columns; *P,0.05, **P,0.01 and ***P,0.001. Median and
IQR are depicted in the scatter plots. (B) Gating strategy to distinguish the T-betdimEomeshi (red arrow) and T-bethiEomesdim (blue arrow) memory
population and subsequent expression patterns of PD-1, CD160 and 2B4 in a HIV infected subject. (C) The frequency of PD-1, CD160, 2B4 and PD-1+
CD160+2B4+ on total T-betdimEomeshi (red) and T-bethiEomesdim (blue) CD8+ T cells for all untreated HIV infected subjects (n = 52). Statistical analysis
was performed with Wilcoxon matched-pairs single rank test. (D) Gating strategy to distinguish the localization within the T-bet/Eomes axis of total
PD-1+CD160+2B4+ CD8+ T cells for a HIV infected subject. The scatter plot shows the distribution of PD-1+CD160+2B4+ expression between T-
betdimEomeshi (red) and T-bethiEomesdim (blue) CD8+ T cells. Wilcoxon matched-pairs single rank test was conducted to obtain P value. (E) Correlation
analysis between the frequencies of T-betdimEomeshi cells and PD-1, CD160, 2B4 and PD-1+CD160+2B4+ CD8+ T cells in all untreated HIV infected
subjects. Spearman non-parametric test was used to test for correlations.
doi:10.1371/journal.ppat.1004251.g001
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to PD-12 cells. PD-12 cells were more likely to simultaneously
express IFNc and TNF or Granzyme B together with CD107a.
Using multi-parametric flow cytometry analysis, we combined
the measurment of all inhibitory receptors (PD-1, CD160, 2B4)
together with the functional markers (IFNc, TNF, IL-2, CD107a,
Granzyme B) using Boolean gating principles (n = 256 T cell
populations). The populations that were occupied in any HIV-
infected subjects (n = 200) were further assessed using PCA
analysis to determine whether HIV- and CMV-specific CD8+ T
cells could be differentiated based on the combination of these
Figure 2. HIV- and CMV-specific CD8+ T cell expression of inhibitory receptors and T-bet/Eomes in untreated HIV infection. (A)
Gating strategy illustrating the localization within the T-bet/Eomes axis of HIV- (red) and CMV-specific CD8+ T cells (blue). (B) Distribution within the
T-betdimEomeshi and T-bethiEomesdim population of HIV- and CMV-specific CD8+ T cell responses. All data is derived from the untreated HIV infected
subjects (n = 52). Median and IQR are shown in all graphs and non-parametric Kruskal Wallis test followed by Dunn’s multiple comparison test was
performed to compare all pairs of columns; *P,0.05, **P,0.01 and ***P,0.001. (C) The frequency of PD-1, CD160, 2B4 and PD-1+CD160+2B4+ on
HIV- and CMV-specific CD8+ T cells. Mann-Whitney tests were performed to conclude significance between the groups (median and IQR). (D)
Localization of PD-1+CD160+2B4+ expressing HIV-specific CD8+ T cells (red) within the T-bet/Eomes axis and distribution between the T-
betdimEomeshi and T-bethiEomesdim population. Wilcoxon matched-pairs single rank test was performed to show on significant differences between
the groups. (E) SPICE analysis of inhibitory receptors combinations between the T-betdimEomeshi (red) and T-bethiEomesdim (blue) population for HIV-
specific CD8+ T cells. Median and IQR are shown for all bars and Wilcoxon matched-pairs single rank tests were performed to compare outcomes
between groups; *P,0.05. Permutation test was performed between the pie charts.
doi:10.1371/journal.ppat.1004251.g002
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markers (Figure 4B). A significant separation between the HIV-
and CMV-specific responses was observed in terms of the PC1 and
PC2 dimensions (Figure 4B) and confirmed by a Kolmogorov-
Smirnov (KS) test, like previously described [46]. The KS test
determines the probability that the two groups were drawn from
the same distribution, where a P-value of 1 signifies that the groups
were drawn from the same distribution. Particularly, the
distributions of the PC2 scores for the two groups were shown
to be derived from different distributions (D = 0.60, P,0.001).
Additionally, the PC1 scores also showed significant differences
between the groups (D = 0.46, P = 0.01).
We next evaluated specific correlations between functional
markers and the T-bet/Eomes axis. The MFI of Eomes in HIV-
specific CD8+ T cells was negatively associated with the co-
expression of IFNc, TNF, CD107a and Granzyme B (P,0.001,
r =20.72) and positively associated with single CD107a produc-
tion (P = 0.004, r = 0.57; Figure 4C). The MFI of T-bet in HIV-
specific CD8+ T cells was primarily correlated to co-expression of
IFNc, TNF and Granzyme B (P = 0.011, r = 0.52) (data not
shown). Next, we assessed whether specific functional combina-
tions were differentially distributed between the T-betdimEomeshi
and T-bethiEomesdim HIV-specific CD8+ T cells by SPICE
analysis. These analyses confirmed a polyfunctional diversity
between the groups (P,0.001, permutation test) and that single
production of CD107a (P,0.001), or together with IFNc
(P = 0.012), was elevated for T-betdimEomeshi cells. In contrast,
co-production of IFNc, TNF and CD107a (P = 0.027) and IFNc,
CD107a and Granzyme B (P = 0.005) was expressed at higher
frequencies by T-bethiEomesdim cells (Figure 4D). We found
similar associations for CMV-specific CD8+ T cells, showing that
T-betdimEomeshi cells particularly expressed high single produc-
tion of CD107a, or together with IFNc, while diverse combina-
tions of all cytokines/cytotoxins were elevated within the T-
bethiEomesdim population (Figure S3). Altogether, our data
suggests that increased expression of Eomes is linked to a profile
of increased exhaustion for both HIV- and CMV-specific CD8+ T
cells.
In order to further assess the link between T-bet and Eomes
with cytolytic functions, we recruited 5 HLA-A*0201+ donors with
identified HIV Pol ILKEPVHGV (IV9)-, HIV/SL9-, and CMV/
NV9-specific CD8+ T cell responses. The effector functions were
examined using tetramers or pentamers and cognate epitope
stimulations. In agreement with the overlapping peptide stimula-
tions, we found that resting HIV-SL9/IV9-tet+ cells showed
increased expression of Eomes that was coupled to lower ex vivo
expression of Granzyme B and perforin compared to CMV/NV9-
tet+ cells. However, most HIV-SL9/IV9-tet+ cells were found to
have high expression levels of Granzyme A (Figure S4A–B).
Correlation analysis confirmed strong associations between the
frequencies of cytolytic markers (perforin and Granzyme B) with
T-bet/Eomes MFI in virus-specific tet+ cells (Figure S4C).
Analysis on bulk CD8+ T cells further supported that perforin+
Figure 3. MHC class-I tetramer stainings of HIV- and CMV-specific CD8+ T cells in chronic HIV infection. (A) Gating strategy of HIV-Gag/
SL9-tet+ (red) and CMV-pp65/NV9-tet+ (blue) CD8+ T cells and their distribution within the T-bet/Eomes axis. (B) The MFI of T-bet and Eomes for Gag/
SL9-tet+ and pp65/NV9-tet+ cells. Paired t-tests were used to compare differences between the groups. (C) The MFI of PD-1, CD160 and 2B4 between
Gag/SL9-tet+ and pp65/NV9-tet+ cells. Paired t-tests were used to compare differences between the groups. (D) Correlation analysis between the
frequency of virus-specific PD-1+CD160+2B4+ cells and MFI of T-bet or Eomes. Spearman non-parametric test was used to test for correlations.
doi:10.1371/journal.ppat.1004251.g003
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Figure 4. Polyfunctional characterization of virus-specific CD8+ T cells in untreated HIV-infected individuals. (A) Distribution of PD-1+
(red) and PD-12 (blue) HIV-specific CD8+ T cells within the T-bet/Eomes axis and linkage to IFNc and TNF, CD107a and Granzyme B expression. (B)
Boolean combinations of all functional and inhibitory markers (n = 256) were combined using PCA, generating a HIV- (orange) and CMV-specific
(green) PC1 and PC2 score for each HIV infected subject (n = 23). (C) Correlations between the MFI of Eomes and IFNc, TNF, CD107a and Granzyme B
or single CD107a secretion. (D) SPICE analysis of all functional combinations between the T-betdimEomeshi (red) and T-bethiEomesdim (blue)
population for HIV-specific CD8+ T cells. Median and IQR are shown for all bars and Wilcoxon matched-pairs single rank tests were performed to
compare outcomes between groups; *P,0.05. Functional combinations where the IQR did not exceed 1% are not depicted in the graph. Permutation
test was performed between the pie charts.
doi:10.1371/journal.ppat.1004251.g004
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and Granzyme B+ cells were primarily T-bethi cells, while
Granzyme A were expressed both within the T-bethi and Eomeshi
compartments (Figure S4D), thus clarifying the high Granzyme A
content of HIV-tet+ cells. Cognate peptide stimulations addition-
ally revealed that HIV-SL9/IV9-epitope specific CD8+ T cells,
independently of whether they were bi- or monofunctional for
IFNc and/or CD107a, showed high expression levels of Eomes,
but variable cytolytic content (Figure S4E). Interestingly, IFNc+
CD107a2 epitope-specific cells showed increased signs of
perforin, Granzyme B and Granzyme A expression compared to
IFNc-CD107a+ and IFNc+CD107a+ cells (Figure S4F). These
analyses further revealed that some HIV epitope-specific IFNc-
CD107a+ cells contained Granzyme A and B, but only in a minor
fraction of the cells, which suggest that monofunctional CD107a+
cells might be highly exhausted (Figure S4E–F).
Increased expression of inhibitory receptors and Eomes is
traced to a transitional memory phenotype
We further traced the expression of the inhibitory receptors to
diverse memory phenotypes using CD45RO, CD27 and CCR7 in
the untreated HIV-infected subjects. The composition of bulk PD-
1+CD160+2B4+ CD8+ T cells was particularly elevated within
the transitional memory (TM; CD45RO+CD27+CCR72) phe-
notype compartment (Figure 5A) as previously described [16].
Consistently, increased co-expression of the inhibitory receptors
was associated with a higher frequency of TM cells, but not
terminally-differentiated effector cells (Eff; CD45RO2CD272
CCR72) (Figure S5A). PD-1+ and CD160+ cells were primarily
found in the TM compartment, while 2B4+ cells were mainly
effector memory (EM; CD45RO+CD272CCR72) and Eff cells.
We next evaluated the phenotypic composition of T-bet and
Eomes expressing cells and as expected found that T-betdimEome-
shi expressing cells were enriched and strongly associated with a
transitional memory phenotype (Figure 5B and Figure S5B).
Conversely, T-bethiEomesdim expression was associated with
increased EM (P = 0.032, r = 0.30) and particularly Eff (P,
0.001, r = 0.69) cell compartmentalization (Figure S5C).
In agreement with other studies, we next confirmed that the
majority of HIV-specific CD8+ T cells (median = 58%) accumu-
lated in the TM compartment (Figure S5D) [26,27]. CMV-specific
CD8+ T cells on the other hand showed a balanced expression of
T-bet and Eomes (Figure 2B) and were thus less encompassed to
the TM compartment (Figure S5E). Similar to before, these results
were further confirmed using HIV/SL9- and CMV/NV9-
tetramers. The HIV/SL9-tet+ cells were indeed enriched within
the TM compartment, while CMV/NV9-tet+ cells displayed a
higher proportion of EM cells (Figure 5C). We next confirmed that
expression levels of Eomes were positively associated (P = 0.04,
r = 0.66) with the proportion of TM virus-specific CD8+ T cells,
where as it was inversely correlated (P = 0.01, r =20.76) with the
frequency of EM virus-specific CD8+ T cells (Figure 5D). These
data suggest that HIV-specific CD8+ T cell expression of
numerous inhibitory receptors is linked to a transitional differen-
tiation phenotype, displaying a T-betdimEomeshi phenotype.
Inflammatory cytokine levels are differentially associated
with T-bet and Eomes expression
Inflammatory cytokines have previously been demonstrated to
inversely regulate the expression levels of T-bet and Eomes in
memory CD8+ T cells [5,47,48]. Therefore, we next aimed to
determine whether the T-betdimEomeshi or T-bethiEomesdim
expression profile of bulk CD8+ T cells was associated with the
levels of IL-12p70, IFNa, TNF and IL-6 in untreated HIV
infection (n = 38). Interestingly, we found tendencies of an inverse
association pattern between T-bet and Eomes in terms of the
inflammatory cytokine levels. While T-bet expression in general
was positively associated with the cytokine plasma levels, Eomes
instead was inversely associated with particularly the levels of
IFNa (P = 0.015, r =20.39) and TNF (P = 0.01, r =20.41)
(Figure S6). These data might implicate that bystander inflamma-
tion influence the bulk CD8+ T cell repertoire towards increased
T-bet or Eomes expression in untreated HIV infection. HIV-
specific CD8+ T cell compartmentalization within the T-
betdimEomeshi or T-bethiEomesdim population was not associated
with the levels of any inflammatory cytokine (data not shown).
HIV-specific CD8+ T cells possess elevated expresion of
inhibitory receptors and Eomes despite long-term ART
To determine whether the viral load had a direct effect on the
expression patterns of Eomes, T-bet and the inhibitory receptors,
we analyzed samples collected before and at 2, 4, 8, 12–16 weeks,
and 5–7 months after ART initiation. These longitudinal analyses
also allowed us to determine the kinetics of expression of these
markers after succesful ART in 24 individuals. Before ART, the
CD4 % was inversely associated (P = 0.015, r =20.38) with the
frequency of T-betdimEomeshi cells (data not shown). Following
initiation of ART, the frequency of T-betdimEomeshi cells in total
CD8+ T cells progressively declined in most individuals. In
contrast, the frequency of T-bethiEomesdim cells remained stable
during the longitudinal assessment (Figure 6A). The decreased
frequency of T-betdimEomeshi cells was related to a similar decay
of the PD-1+CD160+2B4+ population longitudinally after ART
(Figure 6A), where area-under-curve measurements confirmed a
close longitudinal relationship between these populations (P,
0.001, r = 0.71; Figure S7A). We next assessed whether the decay
of the T-betdimEomeshi expressing CD8+ T cell population was a
consequence of fading magnitudes of HIV-specific CD8+ T cells.
However, the absolute decline of the T-betdimEomeshi population
was more pronounced (mean = 7.2%) than the loss of HIV-specific
cells (mean = 0.76%; Figure 6B). Although the T-betdimEomeshi
population was associated (P = 0.003, r = 0.55) with the levels of
CD8+ T cell activation (CD38+HLA-DR+) at baseline (Figure
S7B), the decay of immune activation was not associated (P = 0.41,
r = 0.18) with the fading T-betdimEomeshi population longitudi-
nally based on area-under-curve measurments (data not shown).
Instead, we found that the decay of T-betdimEomeshi cells was
proportional to the recruitment of naı¨ve CD8+ T cells after 6
months on ART (P = 0.026, r =20.45; Figure 6C), indicating that
the expression of Eomes in total CD8+ T cells might represent a
balance between the frequency of naı¨ve versus transitional memory
CD8+ T cells.
We next analyzed the expression pattern of inhibitory receptors
on the HIV-specific CD8+ T cells longitudinally after ART
initiation. The MFI of CD160 and 2B4 remained stable after ART
initiation, while expression levels of PD-1 declined in a hierarchi-
cal manner from baseline until 6 months post-ART initiation (P,
0.001). The pattern of PD-1 expression on HIV-specific CD8+ T
cells was related to the decay in Eomes MFI after ART initiation
(Figure 6D). Despite this relationship between PD-1 and Eomes,
we found no significant decline (P.0.05) in the co-expression of
PD-1, CD160, and 2B4 on HIV-specific CD8+ T cells from before
and 5–7 months after ART initiation (Figure 6E). This was linked
to a steady T-betdimEomeshi expression that persisted over the
entire study period (Figure 6E). Notably, all individuals had fully
suppressed viral load at 5–7 months, and in an attempt to clarify
whether viremia had any effect on T-bet/Eomes or inhibitory
receptors, we divided individuals into two groups based on
Transcriptional Regulation of T Cell Exhaustion
PLOS Pathogens | www.plospathogens.org 9 July 2014 | Volume 10 | Issue 7 | e1004251
whether the subjects had detectable or undetectable viremia after
12–16 weeks on ART. However, no significant differences were
distingushiable between these groups in terms of HIV-specific T-
betdimEomeshi compartmentalization (P = 0.28) or PD-1, CD160,
and 2B4 co-expression (P = 0.11; Figure S7C). Similarly, despite.
10 years on ART (undetectable viral load for .8 years), the
residual HIV-specific CD8+ T cells remained trapped within the
T-betdimEomeshi compartment (Figure 6F). Individuals on long-
term ART showed tendencies of lower co-expression of the
inhibitory receptors compared to individuals at baseline or on
ART for 6 months (Figure 6G). However, the co-expression
frequencies of the anti-CMV response for the long-term treated
individuals was significantly lower than the anti-HIV response
both pre- and post-ART (Figure 6G). Consistently, a majority of
HIV-specific CD8+ T cell remained in the transitional memory
compartment despite long-term therapy (Figure 6H) and showed
similar functional characteristics, except increased Granzyme B
expression pre-ART, before and after 6 months on ART
(Figure 6I). These results together suggest that viral control by
ART for several years does not change the phenotype of HIV-
specific CD8+ T cells, which in turn might be due to retained
elevated levels of Eomes expression.
Discussion
T-bet and Eomes regulate the differentiation process of CD8+ T
cells following encounter with a foreign antigen. Despite the
central role of T-bet and Eomes in differentiation fate decisions,
little is known about their influence on human CD8+ T cell
responses [49]. Here, we show that human bulk and virus-specific
Figure 5. Phenotypic characterization of T-bet and Eomes expression in untreated HIV-infection. (A) Representative plots of an
untreated HIV infected patient showing the distribution of total PD-1+CD160+2B4+ CD8+ T cells (orange) within different memory phenotype
compartments, based on CD45RO, CD27 and CCR7 expression. The distribution of total PD-1+CD160+2B4+ CD8+ T cells was determined in all chronic
untreated HIV infected subjects (B) FACS plots from an HIV infected subject showing the distribution of total T-betdimEomeshi (green) cells within the
different memory phenotype compartments. Also, the phenotypic distribution of total T-betdimEomeshi CD8+ T cells within different memory
compartments for all untreated HIV infected subjects. Median and IQR are shown for all populations. (C) The % of TM and EM compartmentalization
for Gag/SL9-tet+ and pp65/NV9-tet+ cells. Paired t-tests were used to compare differences between the groups. (D) Correlations between the MFI of
Eomes and TM or EM compartmentalization of Gag/SL9-tet+ and pp65/NV9-tet+ cells. Spearman non-parametric test was used to test for correlations.
doi:10.1371/journal.ppat.1004251.g005
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CD8+ T cells expressing high levels of Eomes and low levels of T-
bet, express several inhibitory receptors, display a transitional
differentiation phenotype, exhibit poor functional abilities, and
increased immune activation. This phenotype was unique to HIV-
specific CD8+ T cells as compared to CMV-specific CD8+ T cells,
and aid in explaining the HIV-specific CD8+ T cell subset’s
inability to clear or control the chronic viral replication.
Murine studies have demonstrated that T-bet and Eomes are
centrally connected hub transcription factors that regulate
exhaustion and memory fates of CD8+ T cells [28]. The negative
regulation of inhibitory receptor expression by T-box transcription
factors in CD8+ T cells was first demonstrated to involve direct
binding of T-bet to the promotor region of PD-1, and increased
expression of other inhibitory receptors, like CD160 and 2B4, in
T-bet knock-out models [32]. Further analysis confirmed that T-
bet deficiency in chronic LCMV infection also impact other
neighbouring genes that are directly involved in CD8+ T cell
differentiation and exhaustion, like Tigit, Itgam and IL-18Ra
expression [28]. On the contrary, CD8+ T cell deficiency of
Eomes leads to diminished PD-1 and Blimp-1 expression, as well
as increased IFN-c and TNF co-production following chronic
LCMV infection, implicating that T-bet and Eomes regulate
diverse sub-populations of CD8+ T cells [31]. In our study, T-bet
and Eomes were expressed in distinct patterns and linked to the
exhausted phenotype observed in the murine studies. The loss of
polyfunctional HIV-specific CD8+ T cells was associated with
increased expression levels of Eomes, and down-regulation of T-
bet. These results confirm previous findings by Hersperger et al,
demonstrating decreased expression levels of T-bet in chronic HIV
progressors [33]. We also see tendencies that an increased fraction
of viremic controllers (VL,1000) show increased signs of T-bet
expression, but due to the low number of these subjects (n = 9), no
significant correlations were detected between VL and T-bet/
Eomes compartmentalization of HIV-specific CD8+ T cells in this
cohort. Nevertheless, given that recent studies have shown that T-
bet expression is co-localized both in the nucleus and cytoplasm
[50], our results further suggest that HIV-specific CD8+ T cells in
HIV chronic progressors might have high abundance of T-bet in
the cytoplasm, leading to the inability to repress the expression of
inhibitory receptors and induce cytolytic functions. However, a
recent study by Ribeiro-dos-Santos et al concluded that loss of
cytolytic potential of HIV-specific CD8+ T cells was a conse-
quence of both T-bet and Eomes down-regulation in the chronic
phase of HIV infection [51]. The discrepancies between this study
and our results here are most likely due to the use of different
techniques to observe the levels of transcription factors. While
Ribeiro-dos-Santos et al isolated resting cell populations and used
gene expression analysis to detect mRNA levels, we analyzed
transcription factor protein expression on a single-cell level using
flow cytometry. Both the peptide-stimulation protocol, as well as
the tetramer staining for virus-specific T cells suggested that most
HIV-specific CD8+ T cells had a T-betdimEomeshi phenotype,
indicating that stimulation with HIV antigens per se did not up-
regulate Eomes expression in our analysis. Furthermore, immu-
noblot analysis have previously confirmed that T-bet and Eomes
expression in the nucleus and cytoplasm resembles what is
distinguishable with flow cytometry [50].
The lack of cytolytic functions of HIV-specific CD8+ T cells in
chronic progressors has previously been observed in numerous
studies [52,53,54]. Interestingly, we found a close correlation
between the expression intensity of Eomes and monofunctionality
measured as upregulation of CD107a. Although the CD107a
single positive cells might represent highly exhausted cells, HIV-
specific CD8+ T cells have been reported to contain high levels of
Granzyme A [43], which partly was confirmed in our tetramer
and cognate epitope stimulation assays. In addition, Eomes has
been shown to also directly drive effector CD8+ T cell
differentiation in T-bet knock-out mice [3] and therefore, we
cannot conclude that Eomes high cells fail to deliver effector
molecules. However, in experiments using effector (virus-specific)
CD8+ T cells and target cells, the frequency of Granzyme B and
perforin positive CD8 T cells is proportional to the percentage of
target cells being lysed, while Granzyme A, -K and CD107a are
not necessarily associated with specific lysis of cells [43,52,55]. T-
bet has previously also been shown, in chromatin immunoprecip-
itation coupled with microarray analysis (ChIP-ChIP), to bind and
promote increased gene expression of Granzyme B and perforin in
T cells [56]. These data therefore suggest that HIV-specific CD8+
T cells in chronic progressors do not contain the proper cytotoxic
granules to kill virus infected cells potentially due to poor up-
regulation of T-bet.
The process of CD8+ T cell exhaustion is thought to be a
consequence of increased antigen load, inflammation, and other
events that drive the cells to an end-stage of their life cycle, where
they lose the ability to induce effector functions. This hypothesis is
supported by the fact that chronically high antigen levels cause T
cell exhaustion during chronic viral infections [57]. In addition,
HIV-infected individuals with low viral load generally have higher
T cell polyfunctionality [25] and lower expression of inhibitory
receptors on CD4+ T cells [58]. However, not all elite controllers
show low expression of inhibitory receptors (unpublished obser-
vations) and despite viral control by ART, the functional
chracteristics of HIV-specific CD8+ T cells are not fully restored
[25,53,59]. Whether the state of exhaustion therefore is directly
proportional to antigen burden and only due to chronicity is
therefore not entirely clear. Instead, previous studies have shown
that elevated HIV-specific CD8+ T cell expression of PD-1 occurs
during early HIV infection and remains high in the chronic phase
[60], possibly due to immune activation and the inability of CD8+
T cells to rest (M.R.B./M.B. unpublished observations). We, and
Figure 6. Longitudinal characterization of CD8+ T cell exhaustion and T-bet/Eomes expression following ART initiation. (A)
Longitudinal analysis from baseline (same day as ART initiation) and 6 months post ART for total PD-1+CD160+2B4+ (black), T-betdimEomeshi (red)
and T-bethiEomesdim (blue) expression on CD8+ T cells (n = 24). (B) The decay of HIV-specific CD8+ T cell magnitude (grey) and frequency T-
betdimEomeshi (red) post ART. (C) The frequency of naı¨ve (asparagus) and T-betdimEomeshi (red) expressing CD8+ T cells longitudinally post ART and
Spearman correlation analysis between the area-under-curve (AUC) longitudinally for naı¨ve and T-betdimEomeshi expressing cells. Graphs illustrating
the changes in frequency of (D) MFI of Eomes (red), PD-1 (green), CD160 (orange) and 2B4 (pink) expression, and (E) % of PD-1+CD160+2B4+ (black)
and T-betdimEomeshi (red) expression from baseline and longitudinally after 6 months on ART. All time-points represents the mean and 95% CI. (F)
Distribution of HIV-specific CD8+ T cells within the T-betdimEomeshi and T-bethiEomesdim population after.10 years on ART (n = 12). (G) Frequency of
HIV-specific PD-1+CD160+2B4+ CD8+ T cells at baseline (red), 6 months (green), .10 years on ART (blue) and CMV-specific PD-1+CD160+2B4+ CD8+
T cells .10 years on ART (orange). (H) Memory phenotype distribution of HIV-specific CD8+ T cells at baseline (red), 6 months (green) and .10 years
on ART (blue). (I) Frequency of each individual function (of total HIV-specific response) before (red) and 6 months after ART (green) (n = 12). For G–I,
median and IQR are provided for the bars, where (G–H) Kruskal Wallis test followed by Dunn’s multiple comparison test was performed to compare 3
or more columns (***P,0.001, *P,0.05) and (I) Wilcoxon single rank tests (*P,0.05) were used for paired comparisons.
doi:10.1371/journal.ppat.1004251.g006
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others [61], have found associations between the state of immune
activation (CD38+HLA-DR+) and Eomes, indicating that Eomes
is up-regulated early after HIV infection as a consequence of
immune activation, sustaining the expression of inhibitory
receptors. However, monocyte activation in terms of sCD14 was
not associated with increased expression of Eomes (data not
shown), and no relationship between Eomes and CD38+HLA-
DR+ CD8+ T cells was observed after ART initiation in
longitudinal measurments. Whether the expression profile of
increased Eomes and lower T-bet is a consequence, or cause, of
chronic immune activation is therefore hard to determine. The
associations between inflammatory cytokine levels and T-bet/
Eomes expression, also suggest that the level of inflammation
might influence the expression ratio between these transcription
factors like previously observed in mice [5,47,48]. Nevertheless,
our results strongly suggest at least that exhaustion of human viral-
specific CD8+ T cells is not associated with T-bet up-regulation
and thus terminal differentiation. These observations support
previous studies showing a lack of association between markers of
T cell exhaustion and terminal-differentiation (KLRG1 and
CD57) in chronic LCMV and HIV infection [62,63]. In
agreement with these observations, our data suggest that less
differentiated (TM) T cells show increased signs of exhaustion in
comparison with EM T cells, possibly due to the reverse actions of
T-bet and Eomes promoting diverse effector functions in the
differentiation machinery. Further molecular delineation, and also
identification of other transcription factors, that regulate T cell
differentiation and exhaustion will therefore be informative for
launching effective memory CD8+ T cell responses against
persistent infections, like HIV, in future therapeutic settings.
Despite over 10 years on therapy, residual HIV-specific CD8+
T cells showed high expression levels of Eomes, inhibitory
receptors and an intermediate differentiation status. The sustained
co-expression of inhibitory receptors on HIV-specific CD8+ T
cells was surprising as other studies have distinguished decreased
PD-1 and CD160 expression after ART administration [16].
However, the longitudinal follow-up in this study was shorter (6
months post ART initiation) and after assesing the combined
expression of PD-1, CD160, and 2B4 in individuals with .10
years on ART we found that these levels were lower. The
longitudinal assessment of individuals initiating ART, nevertheless
provided evidence that most HIV-specific CD8+ T cells showed
elevated levels of inhibitory receptors and sustained expression
levels of Eomes, compared to CMV-specific CD8+ T cells.
Similarily, despite ART administration for 6 months, the HIV-
infected subjects showed no significant improvement of functional
characteristics compared to pre-ART. All of these individuals
where however treated in chronic infection, and studies on
patients initiating ART very early following infection would add
valuable information on the dynamics of these responses. The
persistent exhausted phenotype of virus-specific CD8+ T cells has
also been observed in mice after antigen removal [64] and might
be a consequence of unmethylated promotor regions of inhibitory
pathways [65]. In addition to these data, our findings are
supported by previous results showing that ART introduction or
in vitro stimulations do not increase T-bet expression in HIV-
specific CD8+ T cells [33], potentially through the reverse actions
of Eomes. Altogether these data suggest that the exhausted
phenotype is imprinted in HIV-specific CD8+ T cells during
chronic infection, and remains stable several years with undetect-
able viral load.
In summary, we here show that HIV-specific CD8+ T cells
retain an inverse expression pattern between T-bet and
Eomes, which is highly associated with an exhausted phenotype.
CMV-specific CD8+ T cells instead show increased signs of T-bet
expression that potentially leads to the effector memory responses
akin to those described by Hansen et al that control [66] or clear
pathogenic SIV infection [67]. The sustained expression of Eomes
and inhibitory receptors in/on HIV-specific CD8+ T cells after
long-term ART further suggest that therapeutic strategies aimed at
reinvigorating these responses might fail to elicit efficient responses
to eradicate the viral reservoir. Future HIV vaccine or cure
approaches most probably need to overcome this transcriptional
barrier and induce sustained T-bet expression in order to clear
virus infected cells.
Supporting Information
Figure S1 Expression patterns of inhibitory receptors
and the Eomes/T-bet axis in healthy controls and HIV
infected subjects. (A) Representatives flow plots of the gating
strategy to distinguish a pure CD8+ T cell population and the
expression frequencies of all inhibitory receptors for total CD8+ T cells
in one chronic untreated HIV infected subject, HIV+ (ART2) and
one healthy control subject. (B) Representative patterns of T-bet and
Eomes in conjunction with PD-1, CD160 and 2B4 expression on total
CD8+ T cells in a HIV+ (ART2) subject. Correlations between the
frequencies of T-betdimEomeshi cells and PD-1, CD160, 2B4 and PD-
1+CD160+2B4+ CD8+ T cells in all (C) long-term ART (ART+)
treated HIV+ subjects and (D) healthy controls. Spearman non-
parametric test was used to test for correlations.
(EPS)
Figure S2 Median fluorescence intensity (MFI) ex-
pression of T-bet, Eomes and inhibitory receptors in/
on virus-specific CD8+ T cells. (A) The MFI expression of
T-bet and Eomes between HIV- and CMV-specific CD8+ T cell
responses. All data is derived from the untreated HIV infected
subjects (n = 52). Median and IQR are shown in all graphs and
non-parametric Mann-Whitney tests were performed to compare
differences between the groups. (B) The MFI expression of PD-1,
CD160, 2B4 and PD-1+CD160+2B4+ on HIV- and CMV-
specific CD8+ T cells. Mann-Whitney tests were performed to
conclude significance between the groups (median and IQR).
(EPS)
Figure S3 Functional characteristics of CMV-specific
CD8+ T cells in untreated HIV infection. SPICE analysis of
all functional combinations between the T-betdimEomeshi (red) and
T-bethiEomesdim (blue) population for CMV-specific CD8+ T
cells. Median and IQR are provided for all bars and whiskers.
Wilcoxon matched-pairs single rank tests were performed to
compare outcomes between groups; *P,0.05. Functional combi-
nations where the IQR did not exceed 1% are not depicted in the
graph. Permutation test was performed to test for functional
diversity between the groups (pie charts).
(EPS)
Figure S4 Tetramer analysis and cognate epitope
stimulations for detection of virus-specific CD8+ T cell
effector functions. (A) The expression pattern of HIV-Gag/
SL9-tet+ cells (red) between T-bet or Eomes (Y-axis) and
perforin, Granzyme B or Granzyme A (X-axis) expression. (B)
The frequency of perforin, granzyme B and Granzyme A
expression for HIV-tet+ (red) and CMV-tet+ (blue) cells.
Paired t-tests were used to compare differences between the
groups. (C) Correlation analysis between the frequency of
virus-specific perforin+, Granzyme B+ and Granzyme A+ cells
and MFI of T-bet or Eomes. Spearman non-parametric test
was used to test for significant correlations. (D) The
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relationship between T-bet and Eomes expression with
perforin, Granzyme B and Granzyme A expression for resting
CD8+ T cells. (E) Typical expression pattern of IFNc+
CD107a2 (black), IFNc+CD107a2 (green) and IFNc+
CD107a+ (red) HIV epitope-specific cells for Eomes and
Granzyme A expression. (F) Frequency (mean and 95% CI) of
IFNc+CD107a2 (n = 5; black), IFNc-CD107a+ (n = 5; green)
and IFNc+CD107a+ (n = 5; red) HIV epitope-specific cells
expressing perforin, Granzyme B and Granzyme A. Paired t-
tests showed no significant differences between the groups.
(EPS)
Figure S5 Phenotypic associations of CD8+ T cells in
untreated HIV infection. (A) Correlation analysis between
co-expression of PD-1, CD160 and 2B4 and the transitional
memory (TM) or effector memory (Eff) CD8+ T cell compartment
in all untreated HIV infected subjects (n = 52). Spearman non-
parametric test was used to test for correlations. (B) Correlation
between the frequency of T-betdimEomeshi expressing cells and
compartmentalization to the TM (CD45RO+CD27+CCR72)
phenotype (Spearman non-parametric test). (C) Association
between the frequency of T-bethiEomesdim expressing cells and
Eff or effector memory (EM) compartmentalization (Spearman
non-parametric test). Memory phenotype distribution of (D) HIV-
specific (E) and CMV-specific CD8+ T cells, based on CD45RO,
CD27 ad CCR7 expression. Median and IQR are shown for all
populations.
(EPS)
Figure S6 Cross-sectional correlations between inflam-
matory cytokines and T-bet/Eomes expression in un-
treated HIV infection. Spearman correlation analyses between
plasma levels (pg/mL) of IFNa (n = 38), IL-12p70 (n = 38), IL-6
(n = 38) and TNF (n = 38) and the frequencies of T-betdimEomeshi
or T-bethiEomesdim expressing CD8+ T cells.
(EPS)
Figure S7 Relationship between the longitudinal ex-
pression of T-bet/Eomes, inhibitory receptors and
markers of immune activation. (A) Area-under-curve
measurement (AUC) of PD-1+CD160+2B4+ and T-betdimEomeshi
expressing CD8+ T cells longitudinally post ART, followed by
Spearman non-parametric test to test for significant correlation.
(B) Correlation between the frequency of T-betdimEomeshi and
CD38+HLA-DR+ expression on CD8+ T cells before ART
initiation (Spearman non-parametric test). (C) Frequency of T-
betdimEomeshi and PD-1+CD160+2B4+ expressing CD8+ T cells
between individuals with viral load .40 copies/mL (n = 8; black)
and ,40 copies/mL (n = 14; grey) 12–16 weeks post ART
initiation. Mean and 95% CI are shown and based on the
frequency of the markers after 12–16 weeks in comparison to
baseline. Un-paired t-tests were performed to test for significance
between the groups.
(EPS)
Table S1 HIV RNA levels of longitudinal cohort. Viral
load and CD4 count measurements of the HIV-infected cohort
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